Medovate is a dynamic medical innovation development company dedicated to bringing novel medical technologies, created within the NHS, to market to improve patient care. Backed by investment capital from NVM Private Equity and a private US investor, Medovate is the first company dedicated to the development and commercialisation of innovative medical technologies from within the NHS. By providing funding at a crucial point in development, Medovate will ensure that medtech innovations with high potential identified within the NHS are supported through the clinical trial and regulatory approval phases so that they become products that are ready for market as quickly as possible.